Physician

Michael Philip Hood, M.D.

According to 2025 Medicare claims, Michael Hood, M.D. (NPI: 1386932333) practices ophthalmology in the Oklahoma City, OK market, with the plurality of this provider's patient population coming from Oklahoma, OK. This provider's primary affiliated billing organization is RETINA VITREOUS CENTER, PLLC (NPI: 1811284946; TIN: 27-0159123) and primary practice location at 73013-9791.

Hood's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,388 traditional Medicare patients, billed 51,901 HCPCS/CPT codes, and received $4,242,481 in Medicare payments. The top billing code was 67028 (Injection of drug into eye). Part D data shows 595 prescription claims across 200 beneficiaries totaling $19,571 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 13 records totaling $842. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $1,023,285 to $4,242,481. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $4,139 and ending at $19,571. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	522	2,980	$1,023,285
2016	969	5,780	$2,047,795
2017	639	2,620	$620,448
2018	1,408	13,526	$2,667,363
2019	1,235	7,485	$1,217,175
2020	965	8,070	$1,489,299
2021	1,153	10,941	$2,134,535
2022	1,248	15,685	$2,792,044
2023	1,360	37,416	$3,580,556
2024	1,388	51,901	$4,242,481

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	32	71	$4,139
2016	43	92	$9,167
2017	25	42	$2,224
2018	76	157	$47,766
2019	108	235	$19,898
2020	142	331	$22,198
2021	166	406	$22,758
2022	166	367	$19,050
2023	205	550	$20,891
2024	200	595	$19,571

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
67028	Injection of drug into eye	547	2,274	$93
92014	Established patient complete exam of visual system	1,086	1,686	$85
92012	Established patient problem focused exam of visual system	450	665	$63
92134	Imaging of retina	1,266	3,529	$28
92201	Extended exam of the back part of the eye with retinal drawing	542	702	$17

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Prednisolone Acetate	Prednisolone Acetate	245	7,281	$8,009
Moxifloxacin	Moxifloxacin Hcl	109	1,469	$2,716
Simbrinza	Brinzolamide/Brimonidine Tart	12	796	$2,415
Brimonidine Tartrate	Brimonidine Tartrate	24	1,182	$1,574
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	53	3,800	$763

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	13	$842	RxSight Inc
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Michael Philip Hood, M.D.?

Tedicare shows public-source Medicare data for Michael Philip Hood, M.D. (NPI 1386932333), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Michael Philip Hood, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Michael Philip Hood, M.D.?

Michael Philip Hood, M.D. is linked to RETINA VITREOUS CENTER, PLLC (billing NPI 1811284946) in the available physician profile data.

Does Michael Philip Hood, M.D. have Open Payments data?

Michael Philip Hood, M.D. has 13 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.